MYC and neoplasm: MYC immunostaining was also associated with late-onset (p = 0.026, OR = 3.276; CI 95% = 1.152–9.315), deeper tumor extension (p = 0.045, OR = 2.975, CI 95% = 1.027–8.623), and the presence of distant metastasis (p<0.001, OR = 17.682, CI 95% = 3.914–79.882) (Table 1).